Brainstorm Cell Therapeutics to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston – PR Newswire (press release)
|
Brainstorm Cell Therapeutics to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston
PR Newswire (press release) The event includes clinical and commercial experts who are on-hand to address specific questions regarding the outlook for these products, as well as offer insight into how cell and gene therapies could impact the standard of care in key therapeutic … |
|
Immunotherapy gives doctors new weapon against oral cancer
kcentv.com The FDA began approving immunotherapy drugs such as Opdivo in November of 2016 for use against oral cancer. While there are several immunotherapy approaches, these drugs support the body’s immune system by helping attack cancerous cells. |
Bioscience Technology |
FDA Grants Novartis Breakthrough Therapy Designation for CAR–T Cell Treatment
Bioscience Technology The investigational chimeric antigen receptor T cell (CAR-T) therapy, known as CTL019 was first developed by researchers at the University of Pennsylvania. Novartis and Penn entered into a global collaboration for development and commercialization of … CAR–T Cell Therapy Receives FDA Breakthrough DesignationPharmaceutical Processing Novartis’ (NVS) CTL109 BLA Gets Breakthrough Therapy StatusNasdaq 3 Things In Biotech You Should Learn Today: April 19, 2017Seeking Alpha European Pharmaceutical Review all 15 news articles » |
Big Think |
Meet CRISPR’s Younger Brother, SHERLOCK
Big Think Along with Emmanuelle Charpentier and Jennifer Doudna, Feng Zhang is one of the inventors of CRISPR-cas9 — or “CRISPR” for short — the cut-and-paste method for editing evens that’s taken genetics by storm. In fact, after a bruising legal battle … Japan Prize presented to CRISPR gene-editing inventors in Tokyo ceremonyUC Berkeley |